About PhRMA
The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading innovative biopharmaceutical research companies, which are laser focused on developing innovative medicines that transform lives and create a healthier world. Together, we are fighting for solutions to ensure patients can access and afford medicines that prevent, treat and cure disease. Over the last decade, PhRMA member companies have invested more than $850 billion in the search for new treatments and cures, and they support nearly five million jobs in the United States.
Connect with PhRMA
For information on how innovative medicines save lives, please visit:
www.PhRMA.org
www.VotersforCures.org
www.AmericasMedicines.com
www.Facebook.com/PhRMA
www.X.com/PhRMA
While continuous evaluation and refinement are important, any changes to the federal vaccine recommendation categories or individual vaccine recommendations should begin from the recognition that the current United States childhood and adolescent immunization schedule is the product of decades of rigorous scientific research, ongoing safety monitoring, epidemiologic analysis, and expert review. It reflects extensive evaluation by public health experts, clinicians, and scientific advisory bodies and has been developed specifically to address the disease risks, health care infrastructure, and population needs of the United States.